Showing posts with label influenza. Show all posts
Showing posts with label influenza. Show all posts

Sunday, December 07, 2025

Bird flu gene makes our body's fever defense powerless

Bad news!

"Scientists have discovered that avian influenza viruses have a gene that makes them incredibly resistant to heat, rendering our body's natural defense system – fever – powerless in fighting infection. In fact, higher temperatures actually help the viruses replicate. ..."

"A gene in avian flu viruses protects them against heat generated by a human’s fever, essentially neutralizing one of the body’s prime defenses; higher temps even help the viruses replicate, according to Cambridge and Glasgow university scientists."

From the editor's summary and abstract:
"ditor’s summary
Birds operate at body temperatures several degrees higher than those of mammals, and, like mammals, birds are infected by influenza viruses. Influenza viruses can move between animal hosts, often reassorting their gene segments as they transition. Knowing that the body temperature of humans often elevates when sick, Turnbull et al. investigated whether virus gene segments originating from hot-blooded birds may give the virus an advantage in feverish mammals. They found that a viral polymerase containing an avian origin PB1 subunit indeed allowed the virus to replicate at higher temperatures in vitro and in a hyperthermic mouse model. ...

Structured Abstract
INTRODUCTION
Influenza A viruses circulate in diverse species of birds and periodically spill over to cause severe or fatal infections in humans. Avian influenza A viruses are adapted to replicate in the gastrointestinal tract of birds at ~40° to 42°C. By contrast, human-adapted seasonal influenza A viruses tend to cause mild symptoms and thrive in the cool upper respiratory tract at ~33°C but struggle to replicate in cells cultured at 40°C. Notably, the normal body temperature of avian hosts exceeds that of a typical human fever. ...

RATIONALE
We sought to harness the strain-specific temperature sensitivity of influenza viruses to assess the antiviral potential of febrile temperature in vivo. We hypothesized that elevated temperature can inhibit the replication of human-origin influenza A viruses, whereas avian viruses, adapted to higher temperatures in birds, may be able to resist this defense.

RESULTS
To avoid false comparison, we wanted to engineer viruses that were identical apart from their ability to replicate at different temperatures. Taking advantage of the segmented viral genome, we found that avian-origin PB1 proteins (a component of the viral polymerase) enabled viral replication at higher temperatures.
Notably, the 1918, 1957, and 1968 pandemic influenza viruses all acquired an avian-origin PB1 that enabled temperature-resistant replication, and they were associated with more-severe disease compared with their seasonal descendants.
We used a human-origin laboratory-adapted virus (PR8) that is avirulent in humans for our in vivo experiments. PR8 causes severe disease in mice but, like seasonal influenza A viruses, it replicates poorly at 40°C.
We made a series of chimeric PB1 proteins and mapped two amino acid substitutions that conferred avian-like temperature resistance to PR8.
This allowed us to generate two similar viruses for comparative experiments: one that replicated poorly at 40°C and one “avianized” mutant that replicated effectively at this temperature.
In mice housed under standard conditions, the parental virus and the avianized mutant both caused severe disease.
However, when we simulated a fever in mice by elevating the ambient temperature to increase core body temperature, the mice were protected against the parental virus and experienced relatively mild symptoms. By contrast, the avianized temperature-resistant virus caused severe disease in mice, despite their higher body temperature.

CONCLUSION
Because the avianized mutant that replicates effectively at 40°C in vitro was the only virus that caused severe disease in the presence of a simulated fever, we conclude that elevated temperature itself can be a potent antiviral defense in vivo. ..."

Bird flu gene makes our body's fever defense powerless

Bird flu viruses are resistant to fever, making them a major threat to humans (original news release) "Bird flu viruses are a particular threat to humans because they can replicate at temperatures higher than a typical fever, one of the body’s ways of stopping viruses in their tracks, according to new research led by the universities of Cambridge and Glasgow."



Avian-origin influenza A viruses tolerate elevated pyrexic temperatures in mammals

Thursday, June 26, 2025

A single shot of a flu drug could outperform vaccines—and protect for an entire season. Really!

Only for one season??? I feel duped! 😊 This is an example of incremental progress!

Apparently, the only major benefit of this new drug is that it is more broad spectrum than the usual flu shots, which are targeting only a few strains. Hower, if it is indeed more broad spectrum why do we still need these shots every year to be protected? Hopefully, in the next incremental step, they will attempt to reduce the frequency of shots form every year to perhaps every few years.

Is the AAAS doing advertisement for a pharmaceutical company?

It appears the AAAS also confuses comparisons with the placebo to comparisons with competitor products.

"Flu vaccines spare people severe illness and save many lives, but they have notoriously limited impact when their ingredients don’t match circulating strains of the virus, and the immunity they trigger quickly wanes.

Now, a new approach that relies on a single shot of a long-lasting flu drug outperformed vaccines in a clinical trial—and may one day replace or supplement them. “This this is one of the most exciting recent advances for influenza prevention,” ...

The study enrolled 5000 healthy adults before the flu season started and followed them until after it ended. The highest dose of the drug provided 76.1% protection from disease compared to a placebo shot, reported the developer, Cidara Therapeutics, on 23 June. The effectiveness of the seasonal flu vaccine, as the company stressed in a press release about the results, is only about 40%.

Cidara’s drug, CD388, contains a reformulated version of zanamivir that GSK brought to market in 1999 and that’s approved to both treat and prevent disease. But zanamivir, which targets the viral enzyme neuraminidase, must be repeatedly inhaled. To create a longer-lasting version, Cidara developed a chemical variant of the drug and attached several copies of it to a piece of an antibody called the Fc fragment, engineered to resist being broken down by the human body. The company plans to launch a phase 3 efficacy trial next year."

"... In contrast, CD388 is effective against a wide variety of strains, a study in mice ... shows. ..."

"A new clinical trial shows a single shot of a long-lasting flu drug may protect people for an entire season [???], and it might do so more effectively than vaccines."

From the abstract:
"The ability of influenza virus to undergo rapid antigenic shift to elude humoral immunity highlights the need for effective broad-spectrum influenza antivirals for treatment, prophylaxis and pandemic preparedness. Strategies providing durable, universal influenza protection in healthy and high-risk populations are urgently needed. Here we describe the design and preclinical characterization of CD388, a first-in-class antiviral drug–Fc conjugate (DFC), in mice and cynomolgus macaques. CD388 comprises a multivalent conjugate of the influenza virus neuraminidase inhibitor zanamivir, linked to a CH1–Fc hybrid domain of human IgG1 engineered for extended half-life. CD388 improves the antiviral activity of zanamivir, demonstrating potent, universal activity across influenza A and B viruses, including high pathogenicity and neuraminidase inhibitor resistant strains, a low potential for resistance development and potent efficacy in lethal mouse infection models. These results suggest that CD388 has the potential for universal prevention of influenza A and B in healthy and high-risk populations."


A single shot of a flu drug could outperform vaccines—and protect for an entire season | Science | AAAS




Fig. 1: Structure of CD388 and universal activity against influenza A and B in cell-based CPE and microneutralization assays.


Monday, June 26, 2023

Tricky survival tactics of the flu virus uncovered in new study

Good news! Defeating viral pathogens one trick at a time!

Seems to be an impressive study!

"... The two main viruses that cause the flu — influenza A and B — have existed for centuries and, although some antiviral advances have been made, these bugs have proven extremely difficult to eradicate. ...
The finding hinges on understanding how the virus is able to wield a protein known as PA-X to make myriad cuts in the RNA of host cells without harming its own RNA.
When the flu bug uses this protein to slice up the RNA in its host, it is able to [prevent] the RNA from doing one of its key jobs when it comes to infections – triggering the immune system to fight the bug. It also allows the virus to take over the host cell and create copies of itself in a process known as host shutoff. Yet, somehow the protein doesn't affect the virus' own RNA.
What the researchers found is that the RNA sequence targeted by PA-X is extremely specific. In fact, it's one that exists in abundance in humans and other animals susceptible to infection by the virus, but one that is barely found in the virus' own RNA. ...
an ability that's not been seen in viruses before called self/non-self recognition. It refers to a mechanism by which the virus can differentiate between its own RNA and that of its host. While it's been seen in reverse – host cells being able to tell the difference between themselves and viruses – knowing that the virus itself can do it is new information. ..."

From the abstract:
"Many viruses block host gene expression to take over the infected cell. This process, termed host shutoff, is thought to promote viral replication by preventing antiviral responses and redirecting cellular resources to viral processes. Several viruses from divergent families accomplish host shutoff through RNA degradation by endoribonucleases. However, viruses also need to ensure expression of their own genes. The influenza A virus endoribonuclease PA-X solves this problem by sparing viral mRNAs and some host RNAs necessary for viral replication. To understand how PA-X distinguishes between RNAs, we characterized PA-X cut sites transcriptome-wide using 5' rapid amplification of complementary DNA ends coupled to high-throughput sequencing. This analysis, along with RNA structure predictions and validation experiments using reporters, shows that PA-Xs from multiple influenza strains preferentially cleave RNAs at GCUG tetramers in hairpin loops. Importantly, GCUG tetramers are enriched in the human but not the influenza transcriptome. Moreover, optimal PA-X cut sites inserted in the influenza A virus genome are quickly selected against during viral replication in cells. This finding suggests that PA-X evolved these cleavage characteristics to preferentially target host over viral mRNAs in a manner reminiscent of cellular self versus non-self discrimination."

Tricky survival tactics of the flu virus uncovered in new study

Monday, November 28, 2022

Landmark 20-strain mRNA flu vaccine looks to prevent future pandemics

Good news! Perhaps, we can finally get rid of the annual flu shot!

"An incredible new study published in the journal Science demonstrates the potential for a single mRNA vaccine to provide protection from all 20 known influenza A and B virus subtypes. ...
This new work is far from the first to explore the potential of mRNA vaccine technology to fight influenza. A number of mRNA flu vaccines are in various stages of being trialed. Most recently a team of researchers demonstrated preclinical efficacy of a mRNA vaccine that targets four specific influenza proteins and is believed to offer universal protection against most strains.
But what is particularly unique, and potentially controversial, about this new 20-strain mRNA vaccine is its targeting of many types of influenza that are not currently a problem in humans. The big hypothesis is that delivering a vaccine like this, particularly to very young children, could help prime their immune memory against all influenza subtypes for their entire life. ..."

"An experimental mRNA-based vaccine against all 20 known subtypes of influenza virus provided broad protection from otherwise lethal flu strains in initial tests, and thus might serve one day as a general preventative measure against future flu pandemics, according to researchers from the Perelman School of Medicine at the University of Pennsylvania.
The “multivalent” vaccine, which the researchers ... uses the same messenger ribonucleic acid (mRNA) technology employed in the Pfizer and Moderna SARS-CoV-2 vaccines. ...
In mice, the mRNA vaccine elicited high levels of antibodies, which stayed elevated for at least four months, and reacted strongly to all 20 flu subtypes. Moreover, the vaccine seemed relatively unaffected by prior influenza virus exposures, which can skew immune responses to conventional influenza vaccines. The researchers observed that the antibody response in the mice was strong and broad whether or not the animals had been exposed to flu virus before. ..."

From the abstract:
"Seasonal influenza vaccines offer little protection against pandemic influenza virus strains. It is difficult to create effective prepandemic vaccines because it is uncertain which influenza virus subtype will cause the next pandemic. In this work, we developed a nucleoside-modified messenger RNA (mRNA)–lipid nanoparticle vaccine encoding hemagglutinin antigens from all 20 known influenza A virus subtypes and influenza B virus lineages. This multivalent vaccine elicited high levels of cross-reactive and subtype-specific antibodies in mice and ferrets that reacted to all 20 encoded antigens. Vaccination protected mice and ferrets challenged with matched and mismatched viral strains, and this protection was at least partially dependent on antibodies. Our studies indicate that mRNA vaccines can provide protection against antigenically variable viruses by simultaneously inducing antibodies against multiple antigens."

Landmark 20-strain mRNA flu vaccine looks to prevent future pandemics

Penn Scientists Develop 20-Subtype mRNA Flu Vaccine to Protect Against Future Flu Pandemics Promising results in animal models help pave the way for clinical trials

Wednesday, September 28, 2022

Flu vaccination linked to 40% reduced risk of Alzheimer’s confirmed by larger, follow up study

Good news! This study actually confirms an earlier, more narrow study by the researchers two years earlier

The coming flu season is upon us. I got my flu shot just a few days ago to keep my immune system well trained. 

It is very important to take the shot every year, because we still can not predict exactly which virus strains will actually dominate in the next season.

"People who received at least one influenza vaccine were 40% less likely than non-vaccinated people to develop Alzheimer’s disease over the course of the four years examined, according to a new study from UTHealth Houston. ...
The study came after a link between the flu vaccine and reduced risk of Alzheimer’s disease was discovered by UTHealth Houston researchers two years prior. This research is a significant step up, having analyzed a much larger sample than the previous research, including 935,887 flu-vaccinated patients and 935,887 non-vaccinated patients. ..."

"Concluding remarks
This study found that, through an uncertain mechanism, influenza vaccination was associated with a 40% decrease in the 4-year risk of developing AD in patients 65 years or older. ..."

From the abstract:
"Background:
Prior studies have found a reduced risk of dementia of any etiology following influenza vaccination in selected populations, including veterans and patients with serious chronic health conditions. ...
Conclusion:
This study demonstrates that influenza vaccination is associated with reduced AD risk in a nationwide sample of US adults aged 65 and older."

Flu vaccination linked to 40% reduced risk of Alzheimer’s - study - The Jerusalem Post

Thursday, July 14, 2022

An inactivated multivalent influenza A virus vaccine is broadly protective in mice and ferrets

Good news! Hopefully, it will be available to humans soon!

"A “universal” vaccine for influenza A virus (IAV) is a high priority to protect against seasonal epidemics and for pandemic preparedness. Here, [researchers]  developed a multivalent, inactivated whole-virus vaccine for IAV. The vaccine included four IAV subtypes that conferred protection against multiple antigenically distinct and fully heterosubtypic IAV strains in mice and ferrets. These data support further clinical development of this vaccine."

An inactivated multivalent influenza A virus vaccine is broadly protective in mice and ferrets

Tuesday, January 11, 2022

No more annual flu shot? Researchers find new target for universal influenza vaccine

Oh this is such a disappointing good news! I have been getting my annual flu shots for over 20 years now! How will my well trained immune system respond to that?

"... In a typical year, influenza affects more than 20 million people in the United States and leads to more than 20,000 deaths. ...
Many of the antibodies present in the blood of participants were antibodies already known to recognize either the HA head or stalk. But a collection of new antibodies stood out; the antibodies bound to the very bottom of the stalk, near where each HA molecule is attached to the membrane of the flu virion. ..."

From the abstract:
"Seasonal influenza viruses constantly change through antigenic drift and the emergence of pandemic influenza viruses through antigenic shift is unpredictable. Conventional influenza virus vaccines induce strain-specific neutralizing antibodies against the variable immunodominant globular head domain of the viral hemagglutinin protein. This necessitates frequent re-formulation of vaccines and handicaps pandemic preparedness. ... Vaccination was found to be safe and induced a broad, strong, durable and functional immune response targeting the conserved, immunosubdominant stalk of the hemagglutinin. The results suggest that chimeric hemagglutinins have the potential to be developed as universal vaccines that protect broadly against influenza viruses."

No more annual flu shot? Scripps Research and collaborators find new target for universal influenza vaccine | Scripps Research A new antibody discovered in the blood of some people vaccinated against or infected with influenza can recognize a broad variety of flu viruses.




Tuesday, January 12, 2021

Scientists question is it the flu or COVID?

Caution: If true and confirmed, then disturbing! Do people have the cold/flue or Covid-19? People with flu symptoms are by default tested only for Covid-19? Flu infected counts were unusually low this season?

Saturday, October 10, 2020

A step toward a universal flu vaccine

Good news! This is long overdue! This research has long been neglected despite the annual suffering and deadly outcome of the flu. Covid-19 finally has shown that we are capable of defeating a pathogenic virus when we focus our efforts and bring sufficient resources to bear on a global scale!

"... Researchers at MIT and the Ragon Institute of MIT, MGH, and Harvard are now working on strategies for designing a universal flu vaccine that could work against any flu strain. In a study appearing today, they describe a vaccine that triggers an immune response against an influenza protein segment that rarely mutates but is normally not targeted by the immune system. The vaccine consists of nanoparticles coated with flu proteins that train the immune system to create the desired antibodies. In studies of mice with humanized immune systems, the researchers showed that their vaccine can elicit an antibody response targeting that elusive protein segment, raising the possibility that the vaccine could be effective against any flu strain. ..."

A step toward a universal flu vaccine | MIT News | Massachusetts Institute of Technology A step toward a universal flu vaccine

With computer models and lab experiments, researchers are working on a strategy for vaccines that could protect against any influenza virus.

Thursday, March 26, 2020

By targeting flu-enabling protein, newly discovered antibody may protect against wide-ranging strains

Good news, but dated news (Oct. 2019)! Will we finally develop better flu vaccines! It is an enormous scandal that in the 20th year of the 21st century we are still not able to defeat viruses like influenza, common cold or coronavirus although we have the technology and knowledge to do so!

"A nationwide team of researchers has found an antibody that protects mice against a wide range of potentially lethal influenza viruses, advancing efforts to design of a universal vaccine that could either treat or protect people against all strains of the virus. ... the antibody at the center of the study binds to a protein called neuraminidase, which is essential for the flu virus to replicate in the body"

By targeting flu-enabling protein, newly discovered antibody may protect against wide-ranging strains | Scripps Research The findings could lead to a universal flu vaccine and more effective emergency treatments.

Monday, March 02, 2020

Influenza Dwarfs Coronavirus This Season In Case Numbers And Fatalities

I have previously blogged here about a severe influenza season this year in Germany. Now, we also learnt that this influenza season is serious in the U.S. as well!

CDC: 32 Million Americans Ill with Flu This Season, 18,000 Deaths: The Centers for Disease Control said 18,000 people have died from influenza and related pneumonia in the United States this season.

2019-2020 U.S. Flu Season: Preliminary Burden Estimates (as of 2/22/2020)

Wednesday, January 22, 2020

Full flu vaccination cuts child hospitalizations in half

Good news! Impressive!

Full flu vaccination cuts child hospitalizations in half - ISRAEL21c: Israeli-American study finds fully vaccinating children reduced the risk of hospitalization for complications associated with influenza by 54%.

Sunday, March 03, 2019

Viruses Cause Extensive Neurodegenerative Diseases?

Posted: 3/3/2019



Disclaimer

If confirmed and substantiated, then this is a huge discovery! This has the potential of a paradigm shift or scientific revolution! I am not a scientist or doctor!

Scientists Many Failures Are All Too Human!

Have indeed scientists and doctors seriously underestimated or even arrogantly dismissed viruses like flu for decades? For several decades, neurodegenerative diseases like Alzheimer's or Multiple Sclerosis were a mystery to our best scientists and doctors!

As an example, already as early as 1991 it was discovered that HIV traverses the blood brain barrier and causes damage to the brain and “that when the virus infiltrates the brain, it spurs neuronal death and a loss of synaptic connections” (Source 1; emphasis added). Why was this stunning discovery not immediately exploited and pursued to the fullest extent and immediately applied to other viruses?

It is very shocking to learn again and again how the best scientists and doctors can go down blind alleys for decades or even centuries ignoring or dismissing or wrongly and vigorously contesting other, alternative explanations!

Viruses And The Brain

Here is an excellent and comprehensive article about it. Usually, I am a bit reluctant to rely too much on one article to make bold generalizations, but having previously read many other reports about viruses in the brain, prions etc. I don’t think it is far fetched.

The article makes following bold statements:
  1. That viruses like flu (e.g. H1N1, H5N1, herpes, HIV, encephalitis, measles) cause direct or indirect (via e.g. inflammation or toxins in compromised immune systems or via primed nervous system or via induced gene expression) damage to various brain cells (e.g. in the substantia nigra, oligodendrocytes) resulting in severe neurodegenerative symptoms like Parkinson’s, Alzheimer, dementia, encephalitis lethargica, and Multiple Sclerosis
  2. These viruses are apparently capable of easily passing the blood brain barrier or they infiltrate the brain via major nerves like vagus nerve (via the gut) or lingual nerve (via the nose). We learn that viruses use at least three different ways to traverse the blood brain barrier: a) Direct crossing, b) Via Trojan horse or c) Immune response
  3. Some of the neurodegenerative diseases caused by viruses may not be diagnosed in an individual before years or decades have passed

Shingles And Dementia

An article (Source 3) claims that a shingles infection that strikes the facial nerve important to facial movement (caused by varicella zoster virus) or shingles in the eye (“herpes zoster ophthalmicus”) can cause dementia (“The brain vessel damage that can occur with shingles is similar to what is often seen in dementia”). “Varicella zoster virus lives in about 95 percent of the U.S. adult population, thanks to ... chicken pox. ... but the virus remains, dormant in nerve cells [for the rest of your life] … Recently, scientists have learned more about the virus’s ability to infect arteries [“varicella zoster virus vasculopathy”], increasing the risk of stroke or causing headaches and vision problems. … One recently discovered viral target is the gut. ... the virus haunts the digestive organs’ local system of nerves, known as the enteric nervous system. In the gut, instead of a rash, the virus can cause abdominal pain, ulcers or other problems … detected varicella zoster virus in the saliva of six of 11 patients with unexplained abdominal pain for up to four months … The reactivated virus may also be behind some cases of a painful inflammation of the arteries at the temples called giant cell arteritis. More common in older adults, the disorder causes severe headaches, jaw pain and vision problems, and can lead to blindness. … But surprisingly, the virus appears to hide in very few nerve cells. In autopsy samples of ganglia …, researchers found dormant virus in only 34 of 2,226 [different?] nerve cells, or 1.5 percent” (Source 3; emphasis added).

There is more great information in the article (Source 3)!

Misfolded Proteins And The Brain

Another article (Source 4) claims that amyloid is similar and transmissible like prions. Latest research experimentally confirmed such transmission. “When the misfolded versions [of Amyloid beta] form, they behave like prions, catalyzing the conversion of healthy forms into diseased ones and accumulating in clumps called plaques. … In Parkinson’s Disease, misfolded alpha-synuclein proteins spread through the brain, and in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease), the misfolded, accumulating protein is TDP-43. We should investigate the transmission potential of these diseases as well. … What is the difference between amyloid and prions? Are they part of a spectrum? Are they one and the same? If not, what is the difference?” (Source 4; emphasis added)

What is it now viruses or transmissibility of amyloid or both?


Sources:

  1. PSYCHOSES ASSOCIATED WITH INFLUENZA (published 1919; this link is provided in Source 1, but I listed it separately to stress that we had for several centuries repeated hints of a link between influenza and psychic disorders, which was summarized in this 1919 article)
  2. The Case for Transmissible Alzheimer's Grows What separates a lethal prion from a dementia-associated amyloid plaque? Maybe not much (published 2/7/2019; what bothers me about this article is that the author, Jennifer Frazer, wrote it in such a way that the reader is led to believe she is a researching scientist, she is not)

Saturday, October 11, 2014

Why Are Office Door Knobs Not Self-Disinfectant?

Posted: 10/11/2014


Trigger


Recently read “Germs at the Office Are Often Found on Keyboards and at Coffee Stations”. The article is e.g. about a study how fast infectious disease bugs spread around in an office environment.


Some Questions


Why are office door-knobs not self-disinfectant?
Why are office coffee pot handles not self-disinfectant?
Why are office microwave handles not self-disinfectant?
You catch my drift ...

No Government Mandate Please!

I would think, it would be technologically feasible to make such self-disinfectant appliances based on today’s technology. Perhaps silver nanoparticles?